Skip to ContentSkip to Navigation
Research Pediatrics
University Medical Center Groningen

New Key Publication: Pharmacological inhibition of MEK1/2 signaling disrupts bile acid metabolism through loss of Shp and enhanced Cyp7a1 expression

19 January 2023
Abstract
Abstract

Small molecule inhibitors directed against the RAS-MAPK pathway are used to treat various malignancies, but side effects can result in treatment interruption, morbidity, and mortality. We show that short-term MEK inhibition deregulates the expression of genes involved in bile acid metabolism and consequently causes profound alterations in bile acid metabolism. Our work contributes to understanding the initial mechanisms by which RAS MAPK inhibitors can cause gastrointestinal complications, hepatotoxicity, and related side effects.

Authors:

  • Cristy R.C. Verzijl
  • Ivo P. van de Peppel
  • Roos E. Eilers
  • Vincent W. Bloks
  • Justina C. Wolters
  • Martijn Koehorst
  • Niels J. Kloosterhuis
  • Rick Havinga
  • Mathilde Jalving
  • Dicky Struik
  • Johan W. Jonker

Read more: Biomedicine & Pharmacotherapy: https://www.sciencedirect.com/science/article/pii/S0753332223000586

Last modified:19 January 2023 7.25 p.m.

More news

  • 10 June 2024

    Swarming around a skyscraper

    Every two weeks, UG Makers puts the spotlight on a researcher who has created something tangible, ranging from homemade measuring equipment for academic research to small or larger products that can change our daily lives. That is how UG...

  • 24 May 2024

    Lustrum 410 in pictures

    Lustrum 410 in pictures: A photo report of the lustrum 2024

  • 21 May 2024

    Results of 2024 University elections

    The votes have been counted and the results of the University elections are in!